VCYT 241220 30.00C (VCYT241220C30000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

VCYT241220C30000

Watchlist

11.90
0.000.00%

15min DelayClose Dec 19 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
Zacks 12:00 ET
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
Zacks Dec 16 10:25 ET
Express News | Veracyte Inc : Guggenheim Raises Target Price to $45 From $40
ReutersDec 16 07:17 ET
Those Who Invested in Veracyte (NASDAQ:VCYT) a Year Ago Are up 68%
Yahoo FinanceDec 11 13:14 ET
If You Invested $1000 in Veracyte a Decade Ago, This Is How Much It'd Be Worth Now
Zacks Dec 11 07:35 ET
Express News | Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in Nccn® Prostate Cancer Guidelines
ReutersDec 5 16:05 ET

Comments

Stock_Drift

Sep 15 09:56

$Veracyte (VCYT.US)$

ClydePeternuts

Sep 12 02:17

Cathie Wood and Ark Invest's trade activity from today 9/10
$ARK Innovation ETF (ARKK.US)$ :
Bought $Advanced Micro Devices (AMD.US)$ $DraftKings (DKNG.US)$ $Tempus AI (TEM.US)$
Sold $Unity Software (U.US)$ $Palantir (PLTR.US)$ $Twist Bioscience (TWST.US)$ $Veracyte (VCYT.US)$
By the way..
Palantir $PLTR is on fire this year
It's up over 109% YTD, just got included in the S&P500, and today Bank of America raised their price target to $50 a share
D. E. Shaw owns almost $500 million worth of shares, more than any...

Moomoo AI

Feb 24 08:25

Analysts are slightly more optimistic about Veracyte's losses per share, but expect its revenue growth to slow down substantially compared to its historical 29% growth rate. The wider industry is expected to outpace Veracyte.

Veracyte, Inc. (NASDAQ:VCYT) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Moomoo AI

Oct 28, 2023 08:07

The absence of any insider transactions in the past three months doesn't reveal much. Low insider ownership and previous insider selling at Veracyte sparks less enthusiasm. Investors should be aware of potential risks associated with the company.

14% Of This Veracyte Insider's Holdings Were Sold

7ADDbullcoin

Feb 19, 2023 22:35

$Veracyte (VCYT.US)$ 👍